EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The ERA Registry Annual Report 2023: epidemiology of kidney replacement therapy in Europe, with a focus on age comparisons

Marin W F Hoekstra, Rianne Boenink iD, Marjolein Bonthuis iD, Brittany A Boerstra iD, Megan E Astley, Iris R Montez de Sousa iD, Nikola Gjorgjievski, Halima Resic, Nicos Mitsides, Kristine Hommel, Rebecca Guidotti, Inmaculada Marín Sánchez und 27 weitere

Clinical Kidney Journal · 01.05.2026 · 19 (5)

DOI: 10.1093/ckj/sfag036 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Kidney Journal, online erschienen am 11.02.2026. Verfasst von Marin W F Hoekstra und 38 weiteren Autor:innen. Beteiligte Einrichtung: ERA Registry, Amsterdam UMC location University of Amsterdam, Department of Medical Informatics, Amsterdam, The Netherlands. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ERA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The European Renal Association (ERA) Registry collects data on patients with kidney failure receiving kidney replacement therapy (KRT). This paper presents a summary of the ERA Registry Annual Report 2023, and focuses specifically on comparisons by age. The complete ERA Registry Annual Report 2023 is available in the Supplementary information. For 2023, data were collected from 34 countries in Europe and countries bordering the Mediterranean Sea. Using these data, incidence and prevalence of KRT, kidney transplantation rates, survival probabilities, and expected remaining lifetimes were calculated. In 2023, the ERA Registry covered 519 million people in the participating countries. The incidence of KRT was 151 per million population (pmp). Among incident patients, 29% were aged ≥75 years, 64% were male, and the most common primary renal disease (PRD) was diabetes mellitus (22%). Most patients (83%) started KRT with haemodialysis (HD), 11% started with peritoneal dialysis (PD), and 6% underwent pre-emptive kidney transplantation. On 31 December 2023, the prevalence of KRT was 1101 pmp. Among prevalent patients, 24% were aged ≥75 years, 62% were male, and the most common PRD was of miscellaneous origin (18%). Moreover, 56% of prevalent patients received HD, 5% received PD, and 39% were living with a functioning graft. In 2023, the kidney transplantation rate was 43 pmp, with 69% of kidneys coming from deceased donors. For patients starting KRT between 2014 and 2018, 5-year survival probability was 51%. The proportions of incident and prevalent patients aged ≥75 varied considerably across European countries. In addition, incident patients aged ≥75 were more often male, and had more often hypertension as PRD compared with younger patients. Only 1% of incident patients aged ≥75 received a pre-emptive kidney transplant, while among prevalent patients of the same age, 22% was living with a functioning graft.

Schlagwörter

Stichwörter der Autor:innen

dialysisgraft survivalkidney failurekidney transplantationpatient survival

Autor:innen und Institutionen

  • ERA Registry, Amsterdam UMC location University of Amsterdam, Department of Medical Informatics, Amsterdam, The Netherlands.
  • Amsterdam Public Health, Quality of Care, Amsterdam, The Netherlands.
  • ESPN/ERA Registry, Amsterdam UMC location University of Amsterdam, Department of Medical Informatics, Amsterdam, The Netherlands.
  • Amsterdam Public Health, Health Behaviours & Chronic Diseases, Amsterdam, The Netherlands.
  • University Hospital of Nephrology, Skopje, North Macedonia.
  • Faculty of Medicine, Ss. Cyril and Methodius University, Skopje, North Macedonia.

ORCID-Profile: Rianne Boenink, Marjolein Bonthuis, Brittany A Boerstra, Iris R Montez de Sousa, Lukas Buchwinkler, Line M T J Heylen, Shalini Santhakumaran, Nurhan Seyahi, Vianda S Stel, Anneke Kramer

Förderung

  • ERA

Zitieren

APA

Hoekstra, M. W. F., Boenink, R., Bonthuis, M., Boerstra, B. A., Astley, M. E., Montez de Sousa, I. R., Gjorgjievski, N., Resic, H., Mitsides, N., Hommel, K., Guidotti, R., Marín Sánchez, I., Slon-Roblero, M. F., Artamendi, M., Beckerman, P., Buchwinkler, L., Gellert, R., Kuzema, V., Okša, A., …, & Kramer, A. (2026). The ERA Registry Annual Report 2023: epidemiology of kidney replacement therapy in Europe, with a focus on age comparisons. Clinical Kidney Journal, 19(5). https://doi.org/10.1093/ckj/sfag036

Vancouver

Hoekstra MWF, Boenink R, Bonthuis M, Boerstra BA, Astley ME, Montez de Sousa IR, et al. The ERA Registry Annual Report 2023: epidemiology of kidney replacement therapy in Europe, with a focus on age comparisons. Clinical Kidney Journal. 2026;19(5). doi:10.1093/ckj/sfag036

BibTeX
@article{Hoekstra2026,
  author = {Hoekstra, Marin W F and Boenink, Rianne and Bonthuis, Marjolein and Boerstra, Brittany A and Astley, Megan E and Montez de Sousa, Iris R and Gjorgjievski, Nikola and Resic, Halima and Mitsides, Nicos and Hommel, Kristine and Guidotti, Rebecca and Marín Sánchez, Inmaculada and Slon-Roblero, María F and Artamendi, Marta and Beckerman, Pazit and Buchwinkler, Lukas and Gellert, Ryszard and Kuzema, Viktorija and Okša, Adrián and Comas, Jordi and Heylen, Line M T J and Lassalle, Mathilde and Hernandez Ramirez, Sara and Santhakumaran, Shalini and Seyahi, Nurhan and Åsberg, Anders and Weekers, Laurent E and Muñoz-Terol, José M and Trujillo-Alemán, Sara and Memeti Smaili, Fatime and Ots-Rosenberg, Mai and Indridason, Olafur S and Komissarov, Kirill S and Ten Dam, Marc A G J and Stendahl, Maria and Galvão, Ana A and Ortiz, Alberto and Stel, Vianda S and Kramer, Anneke},
  title = {The ERA Registry Annual Report 2023: epidemiology of kidney replacement therapy in Europe, with a focus on age comparisons},
  journal = {Clinical Kidney Journal},
  year = {2026},
  volume = {19},
  number = {5},
  doi = {10.1093/ckj/sfag036}
}
Kostenlos starten →